NCT07321548Completed
Investigating the Gut Microbiota of Individuals With Adenoma, Advanced Adenoma and Colorectal Cancer
Source: ClinicalTrials.gov · Last updated 7 Jan 2026
Brief summary (registry, in English)
This observational study aims to help establish the first molecular test for non-invasive prediction of recurrent adenoma, which will help identify patients at high risk of recurrent adenoma for further colonoscopy examination, and validate the microbial test for CRC screening in different populations.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1757 (actual)
- First submitted
- 18 Dec 2025
- Start date
- 15 Mar 2021
- Primary completion date
- 30 Nov 2024
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Colorectal cancer
- NCT number
- NCT07321548
What you commit to
- Study type: Observational
- Participants enrolled: 1757
- From 15 Mar 2021 to the primary completion date, 30 Nov 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of inflammatory bowel disease
Who the study is looking for
- History of polypectomy or surgical removal of adenoma or CRC within the past 10 years
- Will undergo a scheduled standard colonoscopy examination
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.